HLF · Herbalife Ltd. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.32B | - | $1.27B | $1.26B | $1.22B | - | $1.24B | $1.28B | $1.26B | - |
| Cost of Revenue | $291.10M | - | $284.20M | $276.90M | $265.20M | - | $268.70M | $283.10M | $285.00M | - |
| Gross Profit | $1.03B | - | $989.50M | $982.20M | $956.50M | - | $971.60M | $998.00M | $979.30M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $400.30M | - | $447.60M | $447.90M | $431.90M | - | $444.00M | $502.30M | $492.20M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $29.40M | - | - | - | $30.70M | - | - | - | $29.20M | - |
| Operating Income | $138.40M | - | $125.80M | $132.60M | $122.80M | - | $127.10M | $80.40M | $71.90M | - |
| Interest Expense | $46.80M | - | $51.00M | $53.60M | $52.00M | - | $56.50M | $57.70M | $37.90M | - |
| Income Tax | $30.40M | - | $31.70M | $29.80M | $20.40M | - | $23.20M | $7.50M | $9.70M | - |
| Net Income | $61.90M | - | $43.20M | $49.30M | $50.40M | - | $47.40M | $4.70M | $24.30M | - |
| EPS - Basic | $0.60 | - | $0.42 | $0.48 | $0.50 | - | $0.47 | $0.05 | $0.24 | - |
| EPS - Diluted | $0.57 | - | $0.42 | $0.48 | $0.49 | - | $0.46 | $0.05 | $0.24 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $451.20M | $353.10M | $305.50M | $320.90M | $329.40M | $415.30M | $402.50M | $374.00M | $398.30M | $575.20M |
| Accounts Receivable | $106.00M | $91.90M | $97.80M | $96.20M | $90.10M | $68.90M | $82.00M | $82.80M | $87.90M | $81.20M |
| Inventory | $494.60M | $511.70M | $512.50M | $513.10M | $488.00M | $475.40M | $515.30M | $480.70M | $501.90M | $505.20M |
| Accounts Payable | $88.10M | $99.80M | $88.10M | $91.80M | $85.40M | $70.00M | $86.60M | $81.30M | $89.90M | $84.00M |
| Current Assets | $1.25B | $1.14B | $1.11B | $1.10B | $1.09B | $1.14B | $1.24B | $1.21B | $1.23B | $1.40B |
| Total Assets | $2.88B | $2.79B | $2.70B | $2.74B | $2.68B | $2.73B | $2.65B | $2.60B | $2.65B | $2.81B |
| Current Liabilities | $1.02B | $1.01B | $999.90M | $1.09B | $1.13B | $1.23B | $1.28B | $976.20M | $944.70M | $1.28B |
| Long-term Debt | $1.98B | $1.97B | $2.00B | $1.97B | $1.98B | $1.98B | $1.98B | $2.32B | $2.40B | $2.25B |
| Total Liabilities | $3.31B | $3.30B | $3.30B | $3.39B | $3.42B | $3.53B | $3.61B | $3.64B | $3.68B | $3.87B |
| Stockholders' Equity | ($441.50M) | ($515.10M) | ($612.00M) | ($660.50M) | ($736.00M) | ($801.10M) | ($954.20M) | ($1.04B) | ($1.04B) | ($1.06B) |
| Retained Earnings | ($517.80M) | ($579.70M) | ($665.10M) | ($708.30M) | ($757.60M) | ($808.00M) | ($985.90M) | ($1.03B) | ($1.04B) | ($1.06B) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $113.80M | - | - | - | $200.0K | - | - | - | $13.80M | - |
| Investing Cash Flow | ($11.20M) | - | - | - | ($18.80M) | - | - | - | ($32.80M) | - |
| Financing Cash Flow | $2.00M | - | - | - | ($72.20M) | - | - | - | ($158.20M) | - |
| CapEx | $10.90M | - | - | - | $18.30M | - | - | - | $32.90M | - |
| Free Cash Flow | $102.90M | - | - | - | ($18.10M) | - | - | - | ($19.10M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 77.9% | - | 77.7% | 78.0% | 78.3% | - | 78.3% | 77.9% | 77.5% | - |
| Operating margin | 10.5% | - | 9.9% | 10.5% | 10.1% | - | 10.2% | 6.3% | 5.7% | - |
| EBITDA margin | 12.7% | - | - | - | 12.6% | - | - | - | 8.0% | - |
| Net margin | 4.7% | - | 3.4% | 3.9% | 4.1% | - | 3.8% | 0.4% | 1.9% | - |
| Free cash flow margin | 7.8% | - | - | - | -1.5% | - | - | - | -1.5% | - |
| FCF / Net income | 1.66 | - | - | - | -0.36 | - | - | - | -0.79 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 30.4% | - | 35.1% | 35.6% | 35.4% | - | 35.8% | 39.2% | 38.9% | - |
| Effective tax rate | 32.9% | - | 42.3% | 37.7% | 28.8% | - | 32.9% | 61.5% | 28.5% | - |
| Return on assets | 2.2% | - | 1.6% | 1.8% | 1.9% | - | 1.8% | 0.2% | 0.9% | - |
| Return on equity | -14.0% | - | -7.1% | -7.5% | -6.8% | - | -5.0% | -0.5% | -2.3% | - |
| Return on invested capital | 6.0% | - | 5.2% | 6.3% | 7.1% | - | 8.3% | 3.1% | 3.8% | - |
| Liquidity | ||||||||||
| Current ratio | 1.23 | 1.13 | 1.11 | 1.01 | 0.97 | 0.93 | 0.97 | 1.24 | 1.30 | 1.10 |
| Quick ratio | 0.74 | 0.62 | 0.59 | 0.54 | 0.54 | 0.54 | 0.57 | 0.75 | 0.77 | 0.70 |
| Cash ratio | 0.44 | 0.35 | 0.31 | 0.29 | 0.29 | 0.34 | 0.31 | 0.38 | 0.42 | 0.45 |
| Leverage | ||||||||||
| Debt / Equity | -4.49 | -3.83 | -3.26 | -2.99 | -2.68 | -2.47 | -2.07 | -2.24 | -2.32 | -2.12 |
| Debt / Assets | 0.69 | 0.71 | 0.74 | 0.72 | 0.74 | 0.72 | 0.75 | 0.89 | 0.91 | 0.80 |
| Debt / EBITDA | 11.81 | - | - | - | 12.87 | - | - | - | 23.79 | - |
| Interest coverage | 3.0x | - | 2.5x | 2.5x | 2.4x | - | 2.2x | 1.4x | 1.9x | - |
| Equity multiplier | -6.51 | -5.41 | -4.41 | -4.14 | -3.65 | -3.41 | -2.78 | -2.51 | -2.55 | -2.65 |
| Liabilities / Assets | 1.15 | 1.18 | 1.22 | 1.24 | 1.27 | 1.29 | 1.36 | 1.40 | 1.39 | 1.38 |
| Efficiency | ||||||||||
| Asset turnover | 0.46 | - | 0.47 | 0.46 | 0.46 | - | 0.47 | 0.49 | 0.48 | - |
| Inventory turnover | 0.59 | - | 0.55 | 0.54 | 0.54 | - | 0.52 | 0.59 | 0.57 | - |
| Days sales outstanding | 29d | - | 28d | 28d | 27d | - | 24d | 24d | 25d | - |
| Days inventory outstanding | 620d | - | 658d | 676d | 672d | - | 700d | 620d | 643d | - |
| Days payable outstanding | 110d | - | 113d | 121d | 118d | - | 118d | 105d | 115d | - |
| Cash conversion cycle | 539d | - | 573d | 583d | 581d | - | 606d | 539d | 553d | - |
| Valuation | ||||||||||
| P / E | 25.8x | - | 20.1x | 18.0x | 17.6x | - | 15.6x | 207.8x | 41.9x | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | 1.2x | - | 0.7x | 0.7x | 0.7x | - | 0.6x | 0.8x | 0.8x | - |
| EV / EBITDA | 18.6x | - | - | - | 16.5x | - | - | - | 29.9x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 7.8% | - | 2.7% | -1.7% | -3.4% | - | -3.2% | -2.5% | 1.0% | - |
| Revenue CAGR (3y) | 1.7% | - | -0.6% | -3.3% | -2.9% | - | -4.7% | -6.2% | -5.6% | - |
| Revenue CAGR (5y) | -2.6% | - | -3.5% | -1.3% | -0.7% | - | -0.1% | 0.7% | 1.5% | - |
| Gross profit growth (YoY) | 7.3% | - | 1.8% | -1.6% | -2.3% | - | -0.7% | -1.4% | 2.7% | - |
| Operating income growth (YoY) | 12.7% | - | -1.0% | 64.9% | 70.8% | - | 19.1% | -34.8% | 2.0% | - |
| Net income growth (YoY) | 22.8% | - | -8.9% | 948.9% | 107.4% | - | 10.7% | -92.2% | -17.1% | - |
| EPS growth (YoY) | 16.3% | - | -8.7% | 860.0% | 104.2% | - | 7.0% | -91.7% | -17.2% | - |
| EPS CAGR (3y) | 25.3% | - | -20.3% | -18.3% | -20.1% | - | -25.0% | -66.3% | -43.5% | - |
| EPS CAGR (5y) | -15.6% | - | -16.6% | -10.2% | 8.9% | - | -4.5% | -37.9% | -18.3% | - |
| FCF growth (YoY) | - | - | - | - | 5.2% | - | - | - | - | - |
| FCF CAGR (5y) | 6.1% | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 40.0% | 35.7% | 35.9% | 36.3% | 29.0% | 24.4% | 13.5% | 9.8% | 15.2% | 16.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$5.04B totalWeight Management$2.75B · 54.5%
Targeted Nutrition$1.51B · 30.0%
Energy Sports And Fitness$617.10M · 12.3%
Outer Nutrition$85.00M · 1.7%
Literature Promotional And Other$79.10M · 1.6%
Geographic
$9.80B totalPrimary Reporting Segment$4.76B · 48.6%
Others$2.03B · 20.7%
US$1.01B · 10.3%
IN$889.60M · 9.1%
MX$557.70M · 5.7%
CN$279.10M · 2.8%
VN$278.20M · 2.8%
Peer comparison
Same SIC group: Wholesale-Drugs, Proprietaries & Druggists' Sundries
Comparing HERBALIFE LTD. against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Feb 28, 2014 | $0.1500 |
| Nov 7, 2013 | $0.1500 |
| Aug 9, 2013 | $0.1500 |
| May 10, 2013 | $0.1500 |
| Mar 1, 2013 | $0.1500 |
| Nov 9, 2012 | $0.1500 |
| Aug 10, 2012 | $0.1500 |
| May 11, 2012 | $0.1500 |
| Mar 5, 2012 | $0.1500 |
| Nov 9, 2011 | $0.1000 |
| Aug 11, 2011 | $0.1000 |
| May 20, 2011 | $0.0500 |
| Mar 4, 2011 | $0.0625 |
| Nov 10, 2010 | $0.0625 |
| Aug 10, 2010 | $0.0625 |
| May 6, 2010 | $0.0500 |
| Feb 26, 2010 | $0.0500 |
| Nov 23, 2009 | $0.0500 |
| Aug 26, 2009 | $0.0500 |
| May 20, 2009 | $0.0500 |
| Feb 27, 2009 | $0.0500 |
| Nov 21, 2008 | $0.0500 |
| Aug 25, 2008 | $0.0500 |
| May 28, 2008 | $0.0500 |